Learn about the sample design used for the 2022 National Survey on Drug Use and Health (NSDUH). The report describes the five stages of sample selection, sample weighting and variance estimation procedures, and the impact of the coronavirus disease 2019 (COVID-19) pandemic on sampling.Chapters:Introduces the report, describes the target population, provides a general overview of the 2022 NSDUH sample design, and summarizes the impact of the COVID-19 pandemic on the 2022 NSDUH.Summarizes the 2014 through 2022 coordinated sample design.Discusses the first three stages of selection in greater detail.Describes the 2022 NSDUH hybrid field enumeration and address-based sampling frameDiscusses the fourth and fifth stages of selection.Describes sample weighting and variance estimation procedures for 2022.Summarizes the sample design for the Incentives Field Test

This report describes the sample design for the 2021 National Survey on Drug Use and Health (NSDUH). It describes the target population and the five stages of sample selection, including the impact of coronavirus disease 2019 (COVID-19) pandemic. It also includes information on sample weighting and variance estimation procedures for the 2021 NSDUH.Chapter 1 introduces the report, describes the target population, provides a general overview of the 2021 NSDUH sample design, and summarizes the impact of the COVID-19 pandemic on the 2021 NSDUH. Chapter 2 summarizes the 2014 through 2022 coordinated design, while Chapter 3 discusses the first three stages of selection in greater detail. Chapter 4 describes the fourth and fifth stages of selection. Finally, Chapter 5 describes sample weighting and variance estimation procedures for 2021.The document is available as a PDF.

The goal of this report is to further document the 2019 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors, and documentation of any issue encountered during sample implementation. The 2019 sample design is thoroughly documented in the 2019 NSDUH sample design report (Center for Behavioral Health Statistics and Quality, 2020).

This report compares the estimated (or realized) precisions of a key set of estimates with the targets for the 2012 National Survey on Drug Use and Health (NSDUH). The report provides an overall of the 2012 sample design, describes relative standard errors and design effects, and the use of domain specific design effects for approximating standard error.

The goal of this report is to further document the 2018 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors, and documentation of any issue encountered during sample implementation. The 2018 sample design is thoroughly documented in the 2018 NSDUH sample design report (Center for Behavioral Health Statistics and Quality, 2019a).

The goal of this report is to further document the 2016 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors (RSEs), and documentation of any issues encountered during sample implementation (none in 2016).

This report describes data collection operations for the 2020 National Survey on Drug Use and Health (NSDUH). It details the sampling, counting, and listing operations; data collection staffing; preparation of survey materials; field staff training; data collection (both in-person and web); data collection results; and quality control practices. It also includes information on Coronavirus 2019 safety protocols and training materials.The document is available as a PDF.

This report details the 2019 sample design for the NSDUH and covers the design overview, target population, and stages of sample selection. The design overview describes how the sample design remains consistent with NSDUH’s designs since 1991 and has extended coverage of the sample since then to include additional resident populations. The 2019 target population for this report comprises a civilian, noninstitutionalized population aged 12 years or older residing within the 50 states and the District of Columbia. There are three stages of sample selection that are explained in terms of how to select and aggregate the appropriate census tracts and segments based on state sampling regions (SSRs) for each state.

The goal of this report is to further document the 2015 NSDUH sample experiences, including a comparison of actual sample yields to state and quarter targets, a comparison of achieved and expected design effects (DEFFs) and relative standard errors (RSEs), and documentation of any issues encountered during sample implementation.

This report compares the estimated (or realized) precisions of a key set of estimates with the targets for the 2013 National Survey on Drug Use and Health (NSDUH), formerly called the National Household Survey on Drug Abuse (NHSDA). The comparison was made with targets specified by the Substance Abuse and Mental Health Services Administration (SAMHSA) and with the predicted precisions that statisticians from RTI International anticipated during the design of the survey. In addition, tables of realized DEFFs are provided. This report is organized as follows. Chapter 2 summarizes the 2013 sample design. Chapter 3 describes the calculation of relative standard errors (RSEs) and DEFFs. Chapter 4 presents tables that compare the observed precisions with the expected precisions. Chapter 5 compares median and mean DEFFs. Chapter 6 presents median and mean DEFFs for specific analysis domains. Finally, concluding remarks are provided in Chapter 7.